Detection of human cancer cells with antibodies to human cancer

Chemistry: analytical and immunological testing – For preexisting immune complex or auto-immune disease – Antinuclear

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260112R, 422 61, 436547, 436813, 436808, G01N 3354, G01N 3358, C07G 700

Patent

active

044488904

ABSTRACT:
Specific common nucleolar antigens are found in a broad range of human malignant tumor specimens and have been isolated, extracted and purified. Antibodies and antisera specific to these nucleolar antigens are harvested from non-human hosts and used for detection of human cancer cells. Disclosed are (1) methods for isolating the nucleolar antigens, obtaining them in substantially purified form, producing the specific antibodies, obtaining them in substantially purified form, and using the antisera and antibodies induced by the nucleolar antigens in diagnostic procedures for detecting human cancer cells, and (2) diagnostic kits comprising specific antibodies and antisera.

REFERENCES:
patent: 4296201 (1981-10-01), Ax et al.
Davis et al., Proc. Natl. Acad. Sci. U.S.A., vol. 76, Feb. 1979, pp. 892-896.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Detection of human cancer cells with antibodies to human cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Detection of human cancer cells with antibodies to human cancer , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of human cancer cells with antibodies to human cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-845955

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.